These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21355744)

  • 41. Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
    Kampougeris G; Antoniadou A
    Eye (Lond); 2007 Sep; 21(9):1242-3; author reply 1243. PubMed ID: 17618246
    [No Abstract]   [Full Text] [Related]  

  • 42. Ocular penetration of oral doxycycline in the horse.
    Gilmour MA; Clarke CR; Macallister CG; Dedeo JM; Caudell DL; Morton RJ; Pugh M
    Vet Ophthalmol; 2005; 8(5):331-5. PubMed ID: 16178844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics and bioavailability of moxifloxacin in buffalo calves.
    Pathania R; Sharma SK
    Res Vet Sci; 2010 Aug; 89(1):108-12. PubMed ID: 20202656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats.
    Cárceles CM; Villamayor L; Escudero E; Marín P; Fernández-Varón E
    Vet J; 2007 Mar; 173(2):452-5. PubMed ID: 16377219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Corneal penetration of various aminoglycosides and quinolones].
    Luthardt K; Beck R; Hehl EM; Kundt G; Drewelow B; Guthoff R
    Klin Monbl Augenheilkd; 1998 Sep; 213(3):141-6. PubMed ID: 9793911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Ocular pharmacokinetics and bioavailability of 0.2% ganciclovir in-situ gelling eye drops].
    Zhang JJ; Gao CF; Wang LY
    Zhonghua Yan Ke Za Zhi; 2006 Jul; 42(7):637-41. PubMed ID: 17081425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Moxifloxacin-Gelrite in situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation.
    El-Laithy HM; Nesseem DI; El-Adly AA; Shoukry M
    Arch Pharm Res; 2011 Oct; 34(10):1663-78. PubMed ID: 22076767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraocular concentrations of gatifloxacin and moxifloxacin in the anterior chamber via diffusion through the cornea using collagen shields.
    Kleinmann G; Larson S; Neuhann IM; Hunold AC; LeBoyer R; Hickman S; Mamalis N; Olson RJ
    Cornea; 2006 Feb; 25(2):209-13. PubMed ID: 16371785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of subconjunctival injection of moxifloxacin in humans.
    Matsuura K
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):1019-20. PubMed ID: 22552573
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats.
    Fernández-Varón E; Villamayor L; Escudero E; Espuny A; Cárceles CM
    Vet J; 2006 Sep; 172(2):302-7. PubMed ID: 15908243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioavailability and corneal anti-inflammatory effect of topical suprofen.
    Leibowitz HM; Ryan WJ; Kupferman A; DeSantis L
    Invest Ophthalmol Vis Sci; 1986 Apr; 27(4):628-31. PubMed ID: 3957583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcorneal iontophoresis for delivery of ciprofloxacin hydrochloride.
    Vaka SR; Sammeta SM; Day LB; Murthy SN
    Curr Eye Res; 2008 Aug; 33(8):661-7. PubMed ID: 18696341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Moxifloxacin distribution in the interstitial space of infected decubitus ulcer tissue of patients with spinal cord injury measured by in vivo microdialysis.
    Burkhardt O; Derendorf H; Jäger D; Kumar V; Madabushi R; Röhl K; Barth J
    Scand J Infect Dis; 2006; 38(10):904-8. PubMed ID: 17008236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ocular bioerodible minitablets as strategy for the management of microbial keratitis.
    Weyenberg W; Vermeire A; Dhondt MM; Adriaens E; Kestelyn P; Remon JP; Ludwig A
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3229-33. PubMed ID: 15326145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Penetration of topical ciprofloxacin into the aqueous.
    Ghazi-Nouri SM
    J Cataract Refract Surg; 2003 Nov; 29(11):2043-4; author reply 2043-4. PubMed ID: 14670403
    [No Abstract]   [Full Text] [Related]  

  • 56. The presence of minocycline in the tear film of normal horses following oral administration and its anticollagenase activity.
    Monk CS; Jeong SY; Gibson DJ; Plummer CE
    Vet Ophthalmol; 2018 Jan; 21(1):58-65. PubMed ID: 28598549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Penetration of 0.3% ciprofloxacin, 0.3% ofloxacin, and 0.5% moxifloxacin into the cornea and aqueous humor of enucleated human eyes.
    Silva GCM; Jabor VAP; Bonato PS; Martinez EZ; Faria-E-Sousa SJ
    Braz J Med Biol Res; 2017 Jul; 50(7):e5901. PubMed ID: 28678917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.
    Pawar PK; Majumdar DK
    AAPS PharmSciTech; 2006 Feb; 7(1):E13. PubMed ID: 16584143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relevance of aqueous humor concentrations of fluoroquinolones.
    Scassellati Sforzolini B; Sheets JW; Morris TW
    J Cataract Refract Surg; 2011 Jan; 37(1):217-8. PubMed ID: 21183123
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacokinetics of ciprofloxacin in ponies.
    Dowling PM; Wilson RC; Tyler JW; Duran SH
    J Vet Pharmacol Ther; 1995 Feb; 18(1):7-12. PubMed ID: 7752310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.